NextPoint Therapeutics is focused on advancing precision therapeutics in the field of immuno-oncology, specifically targeting the B7-H7/HHLA2 immune checkpoint pathway to develop first-in-class therapies for cancer patients
NextPoint Therapeutics is focused on advancing precision therapeutics in the field of immuno-oncology, specifically targeting the B7-H7/HHLA2 immune checkpoint pathway to develop first-in-class therapies for cancer patients.